Double‐blind comparison of an oral <i>Escherichia coli</i> preparation and mesalazine in maintaining remission of ulcerative colitis

Abstract

From the results of this preliminary study, probiotic treatment appears to offer another option for maintenance therapy of ulcerative colitis. Additional support is provided for the hypothesis of a pathophysiological role for the intestinal environment in ulcerative colitis.